Live Breaking News & Updates on Amended Form|Page 6

Stay updated with breaking news from Amended form. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SEC Proposes to Require Registered Investment Advisers to Implement a Comprehensive Oversight Framework for Service Providers | Morrison & Foerster LLP

On October 26, 2022, the U.S. Securities and Exchange Commission (SEC) proposed new Rule 206(4)-11 (the “Vendor Oversight Rule” or the “Rule”) to prohibit investment advisers registered. ....

Client Services , Service Provider , Investment Company , Service Providers , A Service Provider Oversight , Morrison Foerster , Exchange Commission , Morrison Foerster Llp , See Oversight Of Service Providers , Investment Advisers Act , Vendor Oversight Rule , Proposing Release , Vendor Oversight , Covered Functions , Covered Function , Categories Identified , Investment Risk , Portfolio Accounting , Trading Desk , Trade Communication , Amended Form , Federal Register , Investment Company Act , Certain Information Providers Acting , Investment Advisers , Proposed Rule ,

NioCorp Developments Ltd.: NioCorp Announces Restatement of Previously Issued Financial Statements

CENTENNIAL, Colo., Oct. 21, 2022 /PRNewswire/ NioCorp Developments Ltd. ("NioCorp" or the "Company") (TSX:NB) (OTCQX:NIOBF) today announced that the Audit Committee of the Board of Directors ....

United States , Jim Sims , Niocorp Developments Ltd , Company Annual Reports On Form , Prnewswire Niocorp Developments Ltd , Audit Committee , Company Common , Exchange Commission , Company Annual Report On Form , Toronto Stock Exchange , Corporate Communications , Lind Global Asset Management , Corp Developments , Affected Periods , Common Share , Common Shares , Annual Report , Year Ended June , Annual Reports , Quarterly Reports , Amended Form , More Information , Corporate Communications Officer , Southeast Nebraska , High Strength , Low Alloy ,

RE Royalties Announces Annual General Meeting of Shareholders, Refiling of Amended Form of Proxy and VIF, and Appointment of Investor Relations Firm

09.09.2022 - All amounts in Canadian dollars unless otherwise statedVANCOUVER, BC / ACCESSWIRE / September 9, 2022 / RE Royalties Ltd. (TSXV:RE) (OTCQX:RROYF) ( RE Royalties or the Company ), a global leader in renewable energy royalty-based financing, . Seite 1 ....

United States , United Kingdom , British Columbia , Re Royalties Ltd , Water Tower Research , Appointment Of Investor Relations Firm , Announces Annual General Meeting , Amended Form , Investor Relations Firm , Pacific Time , Georgia Street , Voting Instruction Form , Information Circular , Wall Street , Water Tower , North America ,

Verano Completes Filing of June 30, 2022 Quarterly Report and Restated Financial Statements

Verano Completes Filing of June 30, 2022 Quarterly Report and Restated Financial Statements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Investorsveranojulianna Paterra , Mediaveranosteve Mazeikadirector , Exchange Commission , Company Quarter Ended , Verano Holdings Corp , Company Amendment No , Quarterly Report , Electronic Document Analysis , Quarter Ended March , Quarter Ended June , Quarter Ended September , Registration Statement , Consolidated Financial Statements , Year Ended December , Amended Form , Zen Leaf , Veranosteve Mazeikadirector , Veranojulianna Paterra , Verano Holdings ,

2022-05-31 | NDAQ:KPRX | Press Release | Kiora Pharmaceuticals Inc.

(2022-05-31 | NDAQ:KPRX) Kiora Pharmaceuticals Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) ....

Salt Lake City , United States , Francina Agosti , Exchange Commission , Company On , Utah Newsfile Corp , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , Nasdaq Hearings Panel , Listing Qualifications Department , Nasdaq Stock Market , Nasdaq Listing Rule , Quarterly Report , Current Report , Annual Report , Amended Form , Late Filing , Nasdaq Listing , Nasdaq Hearings , Ocular Presentation , Rheumatoid Arthritis , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Healthcare 37 , Biotechnology 121 , Usa 8 ,